Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
tom powles
Dec 19, 2023, 09:13 |
Blog
Yüksel Ürün: Congratulations to Tom Powles for being recognized as one of the top influencers in science for the year 2023 by Nature!
Yüksel Ürün, Professor at the Department of Medical Oncology, Ankara University School of Medicine, recently…
Dec 19, 2023, 09:10 |
Insight
Tom Powles: EV/pembro will transform the lives of many patients with this difficult disease
Tom Powles, Director of Barts Cancer Centre, shared a post on X/Twitter: "A big day…
Dec 4, 2023, 15:11 |
Blog
Tom Powles: This is the next chapter IMO
Tom Powles, Director of Barts Cancer Centre, shared a post on X/Twitter: "Treatment for muscle…
Oct 25, 2023, 17:27 |
Insight
Tom Powles: TAR-210 releases Erdafitinib slowly into the bladder by a novel release system
Tom Powles, Director of Barts Cancer Centre, shared on Twitter: ''Something NEW. TAR-210 releases Erdafitinib…
Oct 23, 2023, 15:26 |
Insight
Tom Powles: Enfortumab vedotin and Pembrolizumab improving PFS and OS by 55% and 53% respectively compared to platinum based chemo in 1st line UC (+avelumab in 30%)
Tom Powles, Director of Barts Cancer Centre, shared on Twitter: "Enfortumab vedotin and Pembrolizumab improving…
Oct 21, 2023, 14:04 |
Drugs
Tom Powles: Renal cancer highlights ESMO23
Tom Powles Director of Barts Cancer Centre, shared a post on LinkedIn, saying: "Renal cancer…
Jul 14, 2024, 05:39 |
Blog
Thomas Powles: An intratumoral micro-device releases small amounts of drugs locally to assess efficacy
Thomas Powles posted on X: "An intratumoral micro-device releases small amounts of drugs locally to…
Feb 1, 2024, 15:42 |
Opinion
Thomas Powles: Enfortumab Vedotin and Pembrolizumab shows broad spectrum of activity for Regional Recurrence, Progression-free survival and Overall Survival in all subgroups
Jan 31, 2024, 15:42 |
Blog
Thomas Powles: We need better biomarkers in Urothelial Carcinoma
Thomas Powles, Director of Barts Cancer Centre, shared a post on X/Twitter: "Microsatellite instability (MSIH)…
Sep 21, 2024, 14:04 |
Blog
Enrique Grande: Another practice changing trial in the back
Enrique Grande shared a post on X: ''NIAGARA is the first randomized trial to demonstrate…
3
4
5
6
7
All:
99
Posts:
41 - 50
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Ben Stiller and Prostate Cancer: How He Went Against, How He Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube